Skip to main content

Volume 3 Supplement 1

ESICM LIVES 2015

The role of serum procalcitonin and CRP levels in determining of etiology and outcome in acute exacerbations of COPD

Introduction

This study was conducted to investigate the role of serum procalcitonin and CRP levels in determining etiology, treatment and prognosis in COPD patients with acute exacerbation.

Methods

Fifty-eight hospitalized COPD patients with acute exacerbation were included in the study between January 2008 and March 2011. The diagnosis of COPD was made according to the GOLD guidelines. Serum CRP and procalcitonin (PCT) levels in the first day of hospitalization and then one month later (in a stable period) were studied from all COPD patients. Patients were classified into 4 groups according to the severity of disease and divided into 2 groups according to the PCT levels

( < 0.2 ng/dl and > 0.2 ng/dl).

Results

Four (7%) patients were female and 54 (93%) were male. The mean age was 68.1 ± 10.1. Pathogenic bacterial growth was detected in 16 sputum or bronchial lavage samples. MRSA was found in 3 samples, P. aeruginosa in 3, S. maltophilia in 3, and Enterobacter species was detected in 2 samples. Chlamydia pneumoniae serology was positive in 16 (29%) patients. M. pneumoniae was positive in 8 (15%) patients. The rate of M. pneumoniae was highest (40%) in the severe exacerbation group. PCT level was significantly higher in the Chlamydia positive group (40% vs. 22%). The mean CRP level of COPD patients was 6.7 mg/l in acute attack, and 2.0 mg/l in the stable period. The mean PCT level was 0.50 ng/l in acute attack, and 0.09 ng/l in the stable period. Serum PCT level was found as 0.44 ng/l in severe COPD group, and 0.2 ng/ml in the others (p = 0.02). 27 patients with acute exacerbation of COPD were diagnosed with sepsis. Six patients in the study group died. Mortality rate was higher in high PCT group (13.3% vs. 2.5%).

Conclusions

PCT level can help for determining acute attack and etiology in COPD patients.

Author information

Authors and Affiliations

Authors

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ceylan, O., Ucgun, I., Us, T. et al. The role of serum procalcitonin and CRP levels in determining of etiology and outcome in acute exacerbations of COPD. ICMx 3 (Suppl 1), A796 (2015). https://doi.org/10.1186/2197-425X-3-S1-A796

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/2197-425X-3-S1-A796

Keywords

  • Acute Exacerbation
  • Acute Attack
  • Procalcitonin
  • Stable Period
  • Severe Exacerbation